Previously, we have identified several TFEB activators from curcumin derivatives [15], one of which directly binds to and activates TFEB without inhibiting the MTORC1 pathway and it exerts neuroprotective effects in animal models of Alzheimer’s disease [16]. This evidence concerns the gene TFEB and early-onset autosomal dominant Alzheimer disease.